Cogent Biosciences, Inc. COGT Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s total liabilities & equity?
- Cogent Biosciences, Inc. (COGT) reported total liabilities & equity of $903.01M in Q1 2026.
- How has Cogent Biosciences, Inc.'s total liabilities & equity changed year-over-year?
- Cogent Biosciences, Inc.'s total liabilities & equity increased by 218.2% year-over-year, from $283.8M to $903.01M.
- What is the long-term trend for Cogent Biosciences, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s total liabilities & equity has grown at a 30.2% compound annual growth rate (CAGR), from $250.92M to $937.61M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.